PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21

被引:46
作者
Green, David E. [1 ]
Murphy, Tamara C. [1 ]
Kang, Bum-Yong [1 ]
Searles, Charles D. [2 ]
Hart, Michael [1 ]
机构
[1] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Cardiol, Atlanta, GA 30322 USA
来源
PLOS ONE | 2015年 / 10卷 / 07期
基金
美国国家卫生研究院;
关键词
HYPERTENSION; EXPRESSION; ROSIGLITAZONE; MIR-21; LUNG; ACTIVATION; RESISTANCE; INHIBITION; MOUSE; PTEN;
D O I
10.1371/journal.pone.0133391
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pulmonary hypertension (PH) is a progressive and often fatal disorder whose pathogenesis involves pulmonary artery smooth muscle cell (PASMC) proliferation. Although modern PH therapies have significantly improved survival, continued progress rests on the discovery of novel therapies and molecular targets. MicroRNA (miR)-21 has emerged as an important non-coding RNA that contributes to PH pathogenesis by enhancing vascular cell proliferation, however little is known about available therapies that modulate its expression. We previously demonstrated that peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists attenuated hypoxia-induced HPASMC proliferation, vascular remodeling and PH through pleiotropic actions on multiple targets, including transforming growth factor (TGF)-beta 1 and phosphatase and tensin homolog deleted on chromosome 10 (PTEN). PTEN is a validated target of miR-21. We therefore hypothesized that antiproliferative effects conferred by PPAR. activation are mediated through inhibition of hypoxia-induced miR-21 expression. Human PASMC monolayers were exposed to hypoxia then treated with the PPAR. agonist, rosiglitazone (RSG, 10 mu M), or in parallel, C57Bl/6J mice were exposed to hypoxia then treated with RSG. RSG attenuated hypoxic increases in miR-21 expression in vitro and in vivo and abrogated reductions in PTEN and PASMC proliferation. Antiproliferative effects of RSG were lost following siRNA-mediated PTEN depletion. Furthermore, miR-21mimic decreased PTEN and stimulated PASMC proliferation, whereas miR-21 inhibition increased PTEN and attenuated hypoxia-induced HPASMC proliferation. Collectively, these results demonstrate that PPAR gamma ligands regulate proliferative responses to hypoxia by preventing hypoxic increases in miR-21 and reductions in PTEN. These findings further clarify molecular mechanisms that support targeting PPAR gamma to attenuate pathogenic derangements in PH.
引用
收藏
页数:20
相关论文
共 62 条
[1]   Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival [J].
Alastalo, Tero-Pekka ;
Li, Molong ;
Perez, Vinicio de Jesus ;
Pham, David ;
Sawada, Hirofumi ;
Wang, Jordon K. ;
Koskenvuo, Minna ;
Wang, Lingli ;
Freeman, Bruce A. ;
Chang, Howard Y. ;
Rabinovitch, Marlene .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09) :3735-3746
[2]   Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth [J].
Ameshima, S ;
Golpon, H ;
Cool, CD ;
Chan, D ;
Vandivier, RW ;
Gardai, SJ ;
Wick, M ;
Nemenoff, RA ;
Geraci, MW ;
Voelkel, NF .
CIRCULATION RESEARCH, 2003, 92 (10) :1162-1169
[3]  
[Anonymous], 2010, BASIC SCIENCE OF PUL
[4]   Basic Science of Pulmonary Arterial Hypertension for Clinicians New Concepts and Experimental Therapies [J].
Archer, Stephen L. ;
Weir, E. Kenneth ;
Wilkins, Martin R. .
CIRCULATION, 2010, 121 (18) :2045-U175
[5]   The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study [J].
Azoulay, Laurent ;
Yin, Hui ;
Filion, Kristian B. ;
Assayag, Jonathan ;
Majdan, Agnieszka ;
Pollak, Michael N. ;
Suissa, Samy .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[6]   The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension [J].
Bertero, Thomas ;
Cottrill, Katherine ;
Krauszman, Adrienn ;
Lu, Yu ;
Annis, Sofia ;
Hale, Andrew ;
Bhat, Balkrishen ;
Waxman, Aaron B. ;
Chau, B. Nelson ;
Kuebler, Wolfgang M. ;
Chan, Stephen Y. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (04) :2069-2085
[7]   Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation [J].
Bijli, Kaiser M. ;
Kleinhenz, Jennifer M. ;
Murphy, Tamara C. ;
Kang, Bum-Yong ;
Adesina, Sherry E. ;
Sutliff, Roy L. ;
Hart, C. Michael .
FREE RADICAL BIOLOGY AND MEDICINE, 2015, 80 :111-120
[8]   Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression [J].
Bockmeyer, Clemens L. ;
Maegel, Lavinia ;
Janciauskiene, Sabina ;
Rische, Johanna ;
Lehmann, Ulrich ;
Maus, Ulrich A. ;
Nickel, Nils ;
Haverich, Axel. ;
Hoeper, Marius M. ;
Golpon, Heiko A. ;
Kreipe, Hans ;
Laenger, Florian ;
Jonigk, Danny .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (07) :764-772
[9]   Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway [J].
Brock, Matthias ;
Trenkmann, Michelle ;
Gay, Renate E. ;
Michel, Beat A. ;
Gay, Steffen ;
Fischler, Manuel ;
Ulrich, Silvia ;
Speich, Rudolf ;
Huber, Lars C. .
CIRCULATION RESEARCH, 2009, 104 (10) :1184-U139
[10]   A Role for miR-145 in Pulmonary Arterial Hypertension Evidence From Mouse Models and Patient Samples [J].
Caruso, Paola ;
Dempsie, Yvonne ;
Stevens, Hannah C. ;
McDonald, Robert A. ;
Long, Lu ;
Lu, Ruifang ;
White, Kevin ;
Mair, Kirsty M. ;
McClure, John D. ;
Southwood, Mark ;
Upton, Paul ;
Xin, Mei ;
van Rooij, Eva ;
Olson, Eric N. ;
Morrell, Nicholas W. ;
MacLean, Margaret R. ;
Baker, Andrew H. .
CIRCULATION RESEARCH, 2012, 111 (03) :290-300